Closer to the patient means better decisions: wearable remote monitoring of patients with COVID‐19 lung disease

Código QR

Closer to the patient means better decisions: wearable remote monitoring of patients with COVID‐19 lung disease

Guardado en:

Detalles Bibliográficos
Autores principales:	Elena S. Izmailova, Theodore F. Reiss
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	Therapeutics. Pharmacology RM1-950 Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/9b73514366b241b6bf28dcff92c6321e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Letter]
por: Hendrikx JJMA, et al.
Publicado: (2020)

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions
por: Mahamid M, et al.
Publicado: (2011)

Impact of denosumab on bone mass in cancer patients
por: Brown-Glaberman U, et al.
Publicado: (2013)

Clinical development of nintedanib for advanced non-small-cell lung cancer
por: Takeda M, et al.
Publicado: (2015)

Sodium Bicarbonate Nebulized Therapy in Patients with Confirmed COVID-19
por: Jalil Rashedi, et al.
Publicado: (2020)

Population pharmacokinetic analysis of dupilumab in adult and adolescent patients with asthma
por: Li Zhang, et al.
Publicado: (2021)

Development of best practices in physiologically based pharmacokinetic modeling to support clinical pharmacology regulatory decision‐making—A workshop summary
por: Daphney Jean, et al.
Publicado: (2021)

Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes
por: Nakamura M, et al.
Publicado: (2014)

Effect of statin therapy on vaspin levels in type 2 diabetic patients
por: Al-Azzam SI, et al.
Publicado: (2013)

Niacin as a drug repositioning candidate for hyperphosphatemia management in dialysis patients
por: Shin S, et al.
Publicado: (2014)

The Treatment for a Patient with Cancer of Unknown Primary: A Case Report
por: QingTao Ni MD, et al.
Publicado: (2021)

Evaluating the effects of dexmedetomidine compared to propofol as adjunctive therapy in patients with alcohol withdrawal
por: Lizotte RJ, et al.
Publicado: (2014)

Lymphocyte aggregates persist and accumulate in the lungs of patients with idiopathic pulmonary fibrosis
por: Todd NW, et al.
Publicado: (2013)

A Debate on Vitamin C: Supplementation on the Hotline for Critically Ill Patients with COVID-19
por: Ata Mahmoodpoor, et al.
Publicado: (2020)

Analysis of factors affecting rehospitalization of patients with chronic kidney disease after educational hospitalization
por: Kose E, et al.
Publicado: (2014)

Exposure–response analysis of efficacy and safety for pexidartinib in patients with tenosynovial giant cell tumor
por: Ophelia Yin, et al.
Publicado: (2021)

Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician
por: Guy Hans, et al.
Publicado: (2010)

Population pharmacokinetic and exposure–response analyses of intravenous and subcutaneous rituximab in patients with chronic lymphocytic leukemia
por: Ekaterina Gibiansky, et al.
Publicado: (2021)

Population Pharmacokinetic Model of Plasma and Cellular Mycophenolic Acid in Kidney Transplant Patients from the CIMTRE Study
por: François Riglet, et al.
Publicado: (2020)

Management of chronic hepatitis C virus infection in patients with end-stage renal disease: a review
por: Aguirre Valadez J, et al.
Publicado: (2015)

Neuropeptide Y: a potential theranostic biomarker for diabetic peripheral neuropathy in patients with type-2 diabetes
por: Noo Ree Cho, et al.
Publicado: (2021)

Incidence and management of adverse events in patients with relapsed and/or refractory multiple myeloma receiving single-agent carfilzomib
por: Harvey RD
Publicado: (2014)

Population pharmacokinetics of belantamab mafodotin, a BCMA‐targeting agent in patients with relapsed/refractory multiple myeloma
por: Chetan Rathi, et al.
Publicado: (2021)

A quantitative systems pharmacology modeling platform for evaluating triglyceride profiles in patients with high triglycerides receiving evinacumab
por: Masood Khaksar Toroghi, et al.
Publicado: (2021)

High-dose, short-interval daptomycin regimen was safe and well tolerated in three patients with chronic renal failure
por: Yabuno K, et al.
Publicado: (2013)

Virtual clinical trial simulations for a novel KRASG12C inhibitor (ASP2453) in non‐small cell lung cancer
por: Hiroyuki Sayama, et al.
Publicado: (2021)

Heparin requirements for full anticoagulation are higher for patients on dabigatran than for those on warfarin – a model-based study
por: Edrich T, et al.
Publicado: (2015)

The pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein&ndash;Barr virus disease
por: Heather&nbsp;E Vezina, et al.
Publicado: (2009)

PK/PD modeling analysis for dosing regimen selection of isatuximab as single agent and in combination therapy in patients with multiple myeloma
por: Kimiko Koiwai, et al.
Publicado: (2021)

Pharmacometric analyses of alectinib to facilitate approval of the optimal dose for the first‐line treatment of anaplastic lymphoma kinase–positive non‐small cell lung cancer
por: Joy C. Hsu, et al.
Publicado: (2021)

Comparisons of Four Protein-Binding Models Characterizing the Pharmacokinetics of Unbound Phenytoin in Adult Patients Using Non-Linear Mixed-Effects Modeling
por: Heajin Jun, et al.
Publicado: (2020)

RETRACTION NOTICE: A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients
Publicado: (2021)

Comparisons of different mean airway pressure settings during high-frequency oscillation in inflammatory response to oleic acid-induced lung injury in rabbits
por: Koichi Ono, et al.
Publicado: (2009)

Glibenclamide in patients with poorly controlled type 2 diabetes: a 12-week, prospective, single-center, open-label, dose-escalation study
por: Rambiritch V, et al.
Publicado: (2014)

Author response to: correspondence to: ‘A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients’
por: Jin-Tao Guan, et al.
Publicado: (2021)

Monitoring Tacrolimus Concentrations in Whole Blood and Peripheral Blood Mononuclear Cells: Inter- and Intra-Patient Variability in a Cohort of Pediatric Patients
por: Amedeo De Nicolò, et al.
Publicado: (2021)

PK/PD modeling of FXI antisense oligonucleotides to bridge the dose‐FXI activity relation from healthy volunteers to end‐stage renal disease patients
por: Stefan Willmann, et al.
Publicado: (2021)

A population pharmacokinetic‐pharmacodynamic model of YH12852, a highly selective 5‐hydroxytryptamine 4 receptor agonist, in healthy subjects and patients with functional constipation
por: Siun Kim, et al.
Publicado: (2021)

“Highly Exposed Chinese Herbal Medicine” Combined With Apatinib as Maintenance Treatment Following First-Line or Second-Line Chemotherapy for Extensive-Stage Small-Cell Lung Cancer: A Single-Arm, Prospective Study
por: Mingqi Wang, et al.
Publicado: (2021)

Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes
por: Di Pierro F, et al.
Publicado: (2013)